| Clinical data | |
|---|---|
| Other names | Azagaboxadol |
| Drug class | GABAA-ρ antagonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C6H9N3O |
| Molar mass | 139.158 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Aza-THIP is a selective and moderately potent GABAA-ρ (GABAC receptor) antagonist related to gaboxadol (THIP). Unlike gaboxadol, it is virtually inactive at the GABAA receptor. The drug was first described in the scientific literature by Povl Krogsgaard-Larsen and colleagues by 1979.